Charles River Laboratories Inc. (U.S.), MIDI Inc. (U.S.), QIAGEN N.V. (Netherlands), Shimadzu Corporation (Japan), Siemens Healthcare (Germany), Sigma-Aldrich Corporation (U.S.), and Thermo Fisher Scientific Inc. (U.S.)
(PRWEB) November 30, 2014
The microbial identification market is witnessing significant growth across the globe due to factors such as high prevalence of infectious diseases, technological advancements in products, growing food safety concerns, government initiatives, and higher healthcare expenditure in the emerging geographies. Furthermore, factors such as focus on antimicrobial identification and bioterrorism surveillance are likely to drive the market growth. The key players are focusing on providing innovative products which are cost effective and yield reliable results over a short period. Owing to this, companies focus on partnerships, collaborations, new product launches, and acquisitions in order to attain a leadership position in the market.
The global microbial identification market is estimated at $896.5 million in 2014 and is expected to reach $1,194.1 million by 2019, growing at a CAGR of 5.9% from 2014 to 2019.
Ask for PDf Brochure @ http://www.marketsandmarkets.com/pdfdownload.asp?id=10702182
On the basis of methods, the microbial identification market is segmented into phenotypic and genotypic methods for identification. The genotypic methods showcase a lucrative growth potential and represent the new revenue pockets. The genotypic methods provide reduction in procedural costs along with continuous technological advancements in its products. High growth in these markets can be attributed to its ability to deliver rapid, accurate, and reproducible results that are independent to the growth conditions and physiological state of the microorganisms. Furthermore, this method is used in the identification of viruses. Owing to its advantages, genotypic techniques are used in different areas like clinical diagnostics and pharmaceutical research. The growth in these application areas is supposed to drive the growth of the genotypic market.
Do Inquiry for Further Details @ http://www.marketsandmarkets.com/Enquiry_Before_Buying.asp?id=10702182
Major players in the microbial identification market are Bruker Corporation (U.S.), bioMérieux SA (France), Siemens healthcare (Germany) and Thermo Fisher Scientific, Inc. (U.S.).
MarketsandMarkets is world’s No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.
M&M’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical info graphics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.
North - Dominion Plaza,
17304, Preston Road,
Suite 800, Dallas, TX 75252
Visit MarketsandMarkets Blog@ http://mnmblog.org/market-research/healthcare/biotechnology